Your browser doesn't support javascript.
loading
Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.
Jilek, Joseph L; Frost, Kayla L; Jacobus, Kevyn A; He, Wenxi; Toth, Erica L; Goedken, Michael; Cherrington, Nathan J.
Afiliación
  • Jilek JL; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
  • Frost KL; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
  • Jacobus KA; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
  • He W; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
  • Toth EL; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
  • Goedken M; Rutgers Translational Sciences, Rutgers University, Piscataway, NJ 08901, USA.
  • Cherrington NJ; Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85724, USA.
Acta Pharm Sin B ; 11(12): 3869-3878, 2021 Dec.
Article en En | MEDLINE | ID: mdl-35024313

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Pharm Sin B Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Pharm Sin B Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos